TREATMENT OF SOULIER-BOFFA SYNDROME WITH INTRAVENOUS IMMUNOGLOBULINS - POSSIBLE DISSOCIATION OF CLINICAL AND BIOLOGICAL EFFECTS

被引：1
|
作者：
COSSERAT, J
BLETRY, O
LARAKI, R
HORELLOU, MH
WEILL, B
GODEAU, P
机构：
来源：
REVUE DE MEDECINE INTERNE | 1993年 / 14卷 / 06期
关键词：
D O I：
10.1016/S0248-8663(05)80352-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The treatment of the antiphospholipid syndrome with fetal loss (Soulier-Boffa) is not clearly defined. We have treated 3 women with intravenous-immunoglobulin alone or associated with aspirin, heparin or corticosteroids. All three gave birth to live children. The biological results showed in one case a disappearance of anticardiolipin antibodies, but in two others cases the level of antibodies is still high. These date show that clinical and biological results can be different in Soulier-Boffa syndrome under treatment.
引用
收藏
页码：406 / 406
页数：1
相关论文
共 50 条
  • [21] Successful intravenous interferon-β treatment of chronic hepatitis C in a patient with Bernard-Soulier syndrome
    Suzuki, K
    Hayashi, T
    Akiba, J
    Yoshino, M
    Tajima, K
    Satoh, S
    Shinzawa, H
    Kato, T
    THROMBOSIS RESEARCH, 2000, 100 (03) : 149 - 152
  • [22] High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects
    Liu, Xiaosheng
    Cao, Wei
    Li, Taisheng
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [23] Clinical Efficacy of Intravenous Immunoglobulins in Management of Toxic Shock Syndrome: An Updated Literature Review
    Amreen, Sana
    Brar, Simrandeep K.
    Perveen, Sumera
    Chaudhry, Muhammad Reza
    AlBabtain, Sarah
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (01)
  • [24] Lambert-Eaton (myasthenic) syndrome: Pre-anaesthetic treatment with intravenous immunoglobulins
    Biarnes, A
    Rochera, MI
    ANAESTHESIA, 1996, 51 (08) : 797 - 797
  • [25] On the use of intravenous immunoglobulins for the treatment of the antiphospholipid syndrome - A systematic review and meta-analysis
    Lalmahomed, Tariq Anwar
    Walter, Isabel Johanna
    Lely, Anne Titia
    Bloemenkamp, Katharina Wilhelmina Maria
    Kooiman, Judith
    Limper, Maarten
    AUTOIMMUNITY REVIEWS, 2021, 20 (06)
  • [26] Treatment Experiences with Intravenous Immunoglobulins, Ixekizumab, Dupilumab, and Anakinra in Netherton Syndrome: A Case Series
    Ragamin, Aviel
    Nouwen, Anouk E. M.
    Dalm, Virgil A. S. H.
    van Mierlo, Minke M. F.
    Lincke, Carsten R.
    Pasmans, Suzanne G. M. A.
    DERMATOLOGY, 2023, 239 (01) : 72 - 80
  • [27] Clinical efficacy of intravenous immunoglobulins for the treatment of dermatomyositis skin lesions without muscle disease
    Bounfour, T.
    Bouaziz, J. -D.
    Bezier, M.
    Cordoliani, F.
    Saussine, A.
    Petit, A.
    Juillard, C.
    Bagot, M.
    Rybojad, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (09) : 1150 - 1157
  • [28] Clinical and biological effects of treatment with Anakinra in CINCA syndrome and in systemic onset JIA
    Gattorno, M.
    Ferlito, F.
    Pelagatti, M. A.
    Carta, S.
    Tassi, S.
    Buoncompagni, A.
    Vecchi, A.
    Sironi, M.
    Alessio, M.
    Loy, A.
    Viola, S.
    Rubartelli, A.
    Martini, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 252 - 252
  • [29] High-dose intravenous immunoglobulins for treatment of optic neuritis in Guillain-Barre syndrome
    Lueke, C.
    Dohmen, C.
    Dietlein, T. S.
    Brunner, R.
    Lueke, M.
    Krieglstein, G. K.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2007, 224 (12) : 932 - 934
  • [30] Infections during treatment with biological agents and possible treatment in clinical practice
    Atzeni, Fabiola
    Benucci, Maurizio
    Sarzi-Puttini, Piercarlo
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (03) : 193 - 195
12345